Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1999
10/19/1999US5969107 Monoclonal antibody containing antigen recognition sites which mimic antigenic regions of receptors; diagnostic and therapeutic tool for treatment of tumors
10/19/1999US5969105 Stem cell factor receptor agonists
10/19/1999US5969098 Polypeptide which is microbicide, fungicide, bactericide, antiprotozoa agents
10/19/1999US5969094 Anti-paramyxovirus screening method and vaccine
10/19/1999US5969093 Secreted proteins
10/19/1999US5968921 Compositions and methods for promoting nerve regeneration
10/19/1999US5968824 Administering agent which modulates biochemical pathway in which products of opioid peptide precursor genes participate; antitumor agents; prevention of opacity of intraocular lens after cataract surgery
10/19/1999US5968822 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
10/19/1999US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
10/19/1999US5968818 Nucleic acid coding an enzyme whose presence can be used to acess sensitivity to atherosclerosis
10/19/1999US5968815 Promoter of M. paratuberculosis and its use for the expression of immunogenic sequences
10/19/1999US5968777 DNA encoding seryl t-RNA synthetase
10/19/1999US5968776 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
10/19/1999US5968769 Sequence and analysis of LKP pilin structural genes and the LKP pili operon of nontypable Haemophilus influenzae
10/19/1999US5968737 Method of identifying inhibitors of glutathione S-transferase (GST) gene expression
10/19/1999US5968734 Dna sequences that migrate to new genetic positions and the fusion products; diagnosis of carcinomas, melanomas, and sarcomas suchas ewing's sarcoma
10/19/1999US5968733 Mycobacteriophages and uses thereof
10/19/1999US5968526 Mixing blood sample with peptide isolated from dust mite allergen protein to determine amount of binding which will indicate degree of sensitivity
10/19/1999US5968525 Inactivated Mycolplasma hyopneumoniae and uses therefor
10/19/1999US5968524 Methods and compounds for the treatment of immunologically-mediated psoriasis
10/19/1999US5968522 Dna and antibiodies directed against polypeptides
10/19/1999US5968516 Soybean drug and new method of extracting soybean saponins
10/19/1999US5968514 Polypeptides and proteins for immunology
10/19/1999US5968512 Antibody recognizing endothelial cell ligand for leukocyte CR3
10/19/1999US5968506 Purified telomerase
10/19/1999CA1340790C Method of diagnosis and severity-assessment of human pancreatic disease
10/14/1999WO1999051781A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/14/1999WO1999051750A1 Medicaments for inducing cytotoxic t-cells
10/14/1999WO1999051748A2 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999WO1999051745A2 Dna immunization against chlamydia infection
10/14/1999WO1999051630A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination
10/14/1999WO1999051622A1 Avian il-15 nucleotides and polypeptides, and methods of immunizing poultry using avian il-15
10/14/1999WO1999051269A1 Adjuvant-containing vaccines
10/14/1999WO1999051268A1 Immunomodulatory compositions of mmtv antigens and methods of using same
10/14/1999WO1999051267A1 Hiv-specific cytotoxic t-cell responses
10/14/1999WO1999051266A2 Derivatives of pneumococcal choline binding proteins for vaccines
10/14/1999WO1999051265A1 Nucleic acid encoding hyaluronan synthase and methods of use
10/14/1999WO1999051264A2 Leishmania cysteine proteinases
10/14/1999WO1999051263A2 Methods and modified cells for the treatment of cancer
10/14/1999WO1999051259A2 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
10/14/1999WO1999051258A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE
10/14/1999WO1999051257A1 Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient
10/14/1999WO1999051253A2 Immune response modulation
10/14/1999WO1999051252A1 Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
10/14/1999WO1999051248A1 New combined preparation for the treatment of neoplasic diseases or of infectious diseases
10/14/1999WO1999051247A1 Use of human mesenchymal stem cells to induce t-cell apoptosis
10/14/1999WO1999051226A1 Use of aminothiazole derivatives for preparing medicines for treating diseases causing demyelinization
10/14/1999WO1999051217A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999WO1999051188A2 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999WO1999051187A2 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999WO1999042579A3 Caf1-related protein
10/14/1999WO1999042076A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/14/1999WO1999042075A3 Antibodies against human cd40
10/14/1999WO1999040188A3 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations
10/14/1999WO1999039729A3 Use of heregulin as an epithelial cell growth factor
10/14/1999WO1999037783A9 Live vaccine against brucellosis
10/14/1999WO1999037759A3 Live attenuated salmonella vaccine
10/14/1999WO1999036544A3 Neisseria meningitidis antigens
10/14/1999WO1999036094A9 Composition and method for treating metastatic tumors or cancer induced by cells expressing sv40 tumor antigen
10/14/1999WO1999036090A9 Oral delivery of nucleic acid vaccines by particulate complexes
10/14/1999WO1999034824A3 Tumour vaccines for muc1-positive carcinomas
10/14/1999WO1999031225A3 Human phosphatases
10/14/1999CA2577543A1 Antibody variants and fragments thereof
10/14/1999CA2328294A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination
10/14/1999CA2328181A1 Immunomodulatory compositions of mmtv antigens and methods of using same
10/14/1999CA2326739A1 Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient
10/14/1999CA2326598A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999CA2326388A1 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999CA2325340A1 Derivatives of pneumococcal choline binding proteins for vaccines
10/14/1999CA2325016A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/14/1999CA2324983A1 Hiv-specific cytotoxic t-cell responses
10/14/1999CA2324976A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999CA2228822A1 A polypeptide vector for the delivery of immunogenic epitopes to the immune system using an injection, orally, by a nasal spray, skin patch or transplantable instruments
10/13/1999EP0949333A1 Mutant measles virus antigens and genes encoding the same
10/13/1999EP0948651A1 Recombinant n-smases and nucleic acids encoding same
10/13/1999EP0948646A1 Methods for identifying genes essential to the growth of an organism
10/13/1999EP0948637A1 Live recombinant avian vaccine, using the infectious laryngotracheitis avian virus as vector
10/13/1999EP0948627A2 Glutathionylspermidine synthetase
10/13/1999EP0948625A2 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS)
10/13/1999EP0948624A2 Mutants of streptococcal toxin a and methods of use
10/13/1999EP0948623A2 Isolated mammalian monocyte cell genes; related reagents
10/13/1999EP0948622A1 Human mage-like protein
10/13/1999EP0948621A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
10/13/1999EP0948616A2 Riboflavin mutants as vaccines against actinobacillus pleuropneumoniae
10/13/1999EP0948609A2 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
10/13/1999EP0948597A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
10/13/1999EP0948545A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
10/13/1999EP0948544A1 Monovalent antibody fragments
10/13/1999EP0948534A1 Meningococcus vaccine comprising the valence of bz83 strain
10/13/1999EP0948533A1 ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES
10/13/1999EP0948528A2 $i(STREPTOCOCCUS UBERIS) LACTOFERRIN-BINDING PROTEIN
10/13/1999EP0948518A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
10/13/1999EP0948517A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF
10/13/1999EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999EP0948508A1 Novel coding sequences from herpes simplex virus type-2
10/13/1999EP0948396A1 Microencapsulation process using supercritical fluids
10/13/1999EP0948360A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use
10/13/1999EP0948356A1 Agent for identifying and treating metastasizing tumours
10/13/1999EP0948355A1 Treatment of lupus nephritis with anti-cd40l compounds
10/13/1999EP0948353A1 Methods and compositions for immunomodulation
1 ... 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 ... 1823